BROWSE·page 85 of 327

Browse EX-10 agreements

3,923 matching material contract exhibits.


EXHIBIT 10.1

Autonomix Medical, Inc.

AUTONOMIX MEDICAL, INC.

July 13, 2026

Holder of Common Stock Purchase Warrants

Re: Inducement Offer to Exercise Common Stock Purchase Warrants

Dear Holder:

Autonomix Medical, Inc. (the “Company”) is pleased to offer to you the opportunity to exercise all of the Series C warrants to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), issued to you on November 19, 2025 (the “Existing Warrants”), as set forth on the signature page hereto and currently held by you (the “Holder”). The issuance of the shares of Common Stock underlying the Existing Warrants (the “Warrant Shares”) has been registered for resale pursuant to the registration statement on Form S-3 (File No. 333-291825) (the “Registration Statement”). The Registration Statement is currently effective and, upon exercise of the Existing Warrants pursuant to this letter

EX-10.1·8-K·CIK 1617867·ACC 0001437749-26-023638·Filed Jul 15, 2026, 17:02 ET

Bid Form

[Dealer]

[Dealer Address]

** **

To: Fermi Inc. 620 S. Taylor Street, Suite 301 Amarillo, TX 79101
From: [Dealer]

** **

Re: [Base][Additional] Call Option Transaction

** **

Date: [_], 2026

Dear Ladies and Gentlemen:

EX-10.1·8-K·CIK 2071778·ACC 0001213900-26-078366·Filed Jul 15, 2026, 16:54 ET

EXECUTION VERSION

REFINANCING NOTE PURCHASE AGREEMENT

among

** **

PALMER SQUARE BDC CLO 1, LTD.,
as Issuer

and

** **

PALMER SQUARE BDC CLO 1, LLC,
as Co-Issuer

and

** **

BOFA SECURITIES, INC.,
as Refinancing Initial Purchaser

July 15, 2026

REFINANCING NOTE PURCHASE AGREEMENT, dated July 15, 2026 (this “Agreement”), among Palmer Square BDC CLO 1, Ltd., an exempted company incorporated with limited liability under the laws of the Cayman Islands (the “Issuer”), Palmer Square BDC CLO 1, LLC, a limited liability company formed under the laws of the State of Delaware (the “Co-Issuer”, and together with the Issuer, the “Co-Issuers”) and BofA Securities, Inc. (in its capacity as refinancing initial purchaser, the “Initial Purchaser”).

WHEREAS, the Co-Issuers intend to issue each class of securities set forth on Schedule A hereto and, for purposes of this Agreement: “Notes” means, collectively, the classes of securities set forth on Schedule A hereto;

EX-10.3·8-K·CIK 1794776·ACC 0001213900-26-078363·Filed Jul 15, 2026, 16:52 ET

EXECUTION VERSION

FIRST SUPPLEMENTAL INDENTURE

dated as of July 15, 2026

among

PALMER SQUARE BDC CLO 1, LTD.
as Issuer

and

PALMER SQUARE BDC CLO 1, LLC
as Co-Issuer

and

U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
as Trustee

to

the Indenture, dated as of May 23, 2024,
among the Issuer, the Co-Issuer and the Trustee

THIS FIRST SUPPLEMENTAL INDENTURE, dated as of July 15, 2026 (this “Supplemental Indenture”), among Palmer Square BDC CLO 1, Ltd., an exempted company incorporated with limited liability under the laws of the Cayman Islands, as Issuer (the “Issuer”), Palmer Square BDC CLO 1, LLC, a limited liability company formed under the laws of the State of Delaware (the “Co-Issuer” and, together with the Issuer, the “Co-Issuers”) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), is entered into pursuant to the terms of the Indenture, dated as of May 23, 2024, among the Issuer, the Co-Issuer and the Trustee (as amended, modified or supplemented from time to time, the “*I

EX-10.4·8-K·CIK 1794776·ACC 0001213900-26-078363·Filed Jul 15, 2026, 16:52 ET

EX-10.1

Runway Growth Finance Corp.

Execution Version

Eighth Amendment to Amended and Restated Credit Agreement and Waiver

This Eighth Amendment to Amended and Restated Credit Agreement and Waiver, dated as of July 13, 2026 (the “Amendment”), is made pursuant to that certain Amended and Restated Credit Agreement dated as of April 20, 2022 (as amended, restated, modified or supplemented from time to time, the “Credit Agreement”), among Runway Growth Finance Corp.(f/k/a Runway Growth Credit Fund Inc.), a Maryland corporation, as borrower (the “Borrower”); each Guarantor party thereto; the financial institutions currently party thereto as lenders (the “Lenders”); KeyBank National Association,as administrative agent for the Lenders (in such capacity, together with its successors and assigns, the “Administrative Agent”); CIBC Bank USA, as documentation agent (together with its successors and assigns, the “Documentation Agent”); MUFG Bank, Ltd. (as successor-in-interest to MUFG Union Bank, N.A.), as co-documentation agent (together with its successors and assigns, the “Co-Documentation Agent”); and U.S. Bank Trust Company,

EX-10.1·8-K·CIK 1653384·ACC 0001193125-26-304889·Filed Jul 15, 2026, 16:49 ET

EXHIBIT 10.1

FIRST HAWAIIAN, INC.

COMPANY VOTING AND SUPPORT AGREEMENT

July 12, 2026

First Hawaiian, Inc.
999 Bishop St., 29th Floor
Honolulu, Hawaii 96813

Ladies and Gentlemen:

As a holder of shares of common stock of TriCo Bancshares, a California corporation (the “Company” and such common stock, the “Company Common Stock”), the undersigned (the “Shareholder”) understands that the Company, First Hawaiian, Inc., a Delaware corporation (“Parent”), and Horizon Merger Sub, Inc., a California corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), are concurrently entering into that certain Agreement and Plan of Reorganization and Merger, dated as of the date of this voting and support agreement (this “Agreement” and, such Agreement and Plan of Reorganization and Merger, as it may be amended, modified or supplemented from time to time in accordance with its terms, the “Merger Agreement”), pursuant to which, among other things and subject to the terms and conditions set forth in the Merger Agreement, (i) Merger Sub will merge with and into the Company (the “Merger”), with the Company

EX-10.1·8-K·CIK 36377·ACC 0001104659-26-083898·Filed Jul 15, 2026, 16:23 ET

EX-10.01

Regen BioPharma Inc

SETTLEMENT AND MUTUAL RELEASE AGREEMENT

** **

This Settlement and Mutual Release Agreement (this “Agreement”) entered into on this 14th day of May 2026 by and between by and between the following interested parties: TRILLIUM PARTNERS, LP, a Delaware limited partnership (the “Plaintiff”) and REGEN BIOPHARMA, INC., a Nevada corporation, (a “Defendant”) each of whom are parties to certain now pending matter of civil litigation as identified infra, who collectively are referred to as “**the Parties **“ or individually as, a “Party” as context may require, based upon the terms and conditions as set forth herein:

Recitals

*** ***

WHEREAS, Plaintiff has on or about April 14, 2026 filed unlimited civil complaint (the “Complaint”) in the Superior Court for the State of California County of San Diego (the “SDSC”) further identified by case number 26CU020352C and alleging certain claims against Defendant who has acknowledges service of process of the Complaint (the “Acknowledgement”) on or about April 21, 2026 filed by the Plaintiff;

EX-10.01·8-K·CIK 1589150·ACC 0001493152-26-033364·Filed Jul 15, 2026, 16:18 ET

EX-10.1

Celsius Holdings, Inc.

***EXECUTION VERSION ***

SECOND REFINANCING AMENDMENT dated as of July 15, 2026 (this “Agreement”), relating to the CREDIT AGREEMENT dated as of April 1, 2025 (as amended by the First Refinancing Amendment, dated as of October 2, 2025, and as further amended, supplemented or otherwise modified prior to the date hereof, the “Existing Credit Agreement” and as amended by this Agreement, the “Amended Credit Agreement”), among CELSIUS HOLDINGS, INC., a Nevada corporation (“Holdings”), CELSIUS, INC., a Nevada corporation (the “Company”, together with Holdings, the “Borrowers”), the LENDERS from time to time party thereto, the ISSUING BANKS from time to time party thereto, and UBS AG, STAMFORD BRANCH, as administrative agent (in such capacity, the “Administrative Agent”) and as collateral agent (in such capacity, the “Collateral Agent”) for the Lenders.

EX-10.1·8-K·CIK 1341766·ACC 0001193125-26-304791·Filed Jul 15, 2026, 16:15 ET

EX-10.1

Aspira Women's Health Inc.

SUBORDINATED BUSINESS LOAN AND SECURITY AGREEMENT

**THIS SUBORDINATED BUSINESS LOAN AND SECURITY AGREEMENT **(as the same may be amended,

restated, modified, or supplemented from time to time, this “Agreement”) dated as of July 01, 2026 (the “Effective Date”) among Agile Capital Funding, LLC as collateral agent (in such capacity, together with its

successors and assigns in such capacity, “Collateral Agent”), and Agile Lending, LLC, a Virginia limited liability

company (“Lead Lender”) and each assignee that becomes a party to this Agreement pursuant to Section 12.1 (each individually with the Lead Lender, a “Lender” and collectively with the Lead Lender, the “Lenders”), and ASPIRA WOMEN’S HEALTH INC., A Domestic Delaware Corporation (“Parent”) and its subsidiaries, ASPIRA LABS, INC., A Domestic Delaware Corporation and together with Parent, and the other entities shown as signatories hereto or that are joined from time to time as a Borrower, individually and collectively, jointly and severally,

EX-10.1·8-K·CIK 926617·ACC 0000926617-26-000052·Filed Jul 15, 2026, 16:12 ET

AMENDMENT NO. 1

MARTIN MARIETTA MATERIALS INC

Execution Version

AMENDMENT NO. 1

AMENDMENT NO. 1 dated as of July 10, 2026 (this “Agreement”) among Martin Marietta Materials, Inc., a North Carolina corporation (the “Borrower”), the Lenders (as defined below) party hereto and JPMorgan Chase Bank, N.A. (“JPMCB”), as administrative agent (in such capacity, the “Administrative Agent”). Capitalized terms used but not defined herein shall have the meanings assigned to such terms in the Credit Agreement referred to below.

RECITALS:

EX-10.1·8-K·CIK 916076·ACC 0000950157-26-000802·Filed Jul 15, 2026, 16:09 ET

TERM CREDIT AGREEMENT

MARTIN MARIETTA MATERIALS INC

** **

Exhibit 10.2

** **

Execution Version

$1,500,000,000

TERM CREDIT AGREEMENT

dated as of

July 15, 2026

among

MARTIN MARIETTA MATERIALS, INC.,

The LENDERS from Time to Time Party Hereto

and

JPMORGAN CHASE BANK, N.A.,

as Administrative Agent

GOLDMAN SACHS BANK USA,

as Syndication Agent

DEUTSCHE BANK SECURITIES INC.,

TRUIST BANK,

WELLS FARGO BANK, NATIONAL ASSOCIATION,

PNC BANK, NATIONAL ASSOCIATION,

REGIONS BANK,

and

FIRST-CITIZENS BANK & TRUST COMPANY,

as Documentation Agents

GOLDMAN SACHS BANK USA,

JPMORGAN CHASE BANK, N.A.

DEUTSCHE BANK SECURITIES INC.,

TRUIST SECURITIES, INC.,

WELLS FARGO SECURITIES, LLC,

PNC CAPITAL MARKETS LLC,

REGIONS CAPITAL MARKETS ,

and

FIRST-CITIZENS BANK & TRUST COMPANY,

as Joint Lead Arrangers and Joint Bookrunners

TABLE OF CONTENTS

** **

EX-10.2·8-K·CIK 916076·ACC 0000950157-26-000802·Filed Jul 15, 2026, 16:09 ET

LEAKOUT AGREEMENT

Edgemode, Inc.

LEAKOUT AGREEMENT

This Leakout Agreement (this “Agreement”) is made and entered into as of the date of the last signature hereto (the “Effective Date”), by and among EdgeMode, Inc., a Nevada corporation (the “Company”), and each of the lenders identified on the signature pages hereto (each, a “Lender” and collectively, the “Lenders”) and supersedes, overrides and replaces the previously executed Standstill Agreement dated June 25, 2026.

RECITALS

WHEREAS, each Lender has previously purchased from the Company one or more convertible promissory notes (each, a “Note”), the details of which are set forth on Schedule A attached hereto;

WHEREAS, the Company is seeking to refinance the indebtedness evidenced by the Notes;

WHEREAS, in order to facilitate such refinancing, each Lender had previously agreed to a temporary standstill on June 25, 2026 with respect to certain rights under the applicable Note(s);

WHEREAS, each Lender has agreed to a leakout with respect to remaining balances and certain rights under the applicable Note(s); and

EX-10.1·8-K·CIK 1652958·ACC 0001683168-26-005551·Filed Jul 15, 2026, 16:05 ET